Kyowa Kirin Rolls Out Automated Injection Device of G-Lasta in Japan

Kyowa Kirin on December 6 launched an automatic dosing device of its long-acting G-CSF formulation G-Lasta Subcutaneous Injection 3.6 mg BodyPod (pegfilgrastim) in Japan. Licensed from Amgen K-A, Kyowa Kirin has been marketing G-Lasta in Japan since 2014 for use...read more